AstraZeneca could resume U.S. testing of the company’s Phase III Covid-19 vaccine soon after being paused for more than a month while the U.S. Food and Drug Administration investigates a serious illness that occurred in a patient who received the experimental treatment.
Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of the company’s addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that effectively sidestepped paying billions of dollars in penalties and stopped short of criminally charging its executives or wealthy Sackler family owners.
Eli Lilly hired an independent consultant to review a plant producing the company’s Covid-19 antibody drug after receiving a notice from the U.S. health regulator.
The European Commission signed a contract on behalf of EU states with U.S. drugmaker Johnson & Johnson for the supply of 400 million doses of the company’s Covid-19 vaccine candidate.
Novartis is seeking to repurpose the company’s investigational oral spinal muscular atrophy (SMA) medicine branaplam to treat Huntington’s disease, as the Swiss drugmaker plans a clinical trial after winning U.S. orphan drug designation.
GlaxoSmithKline will move the company’s experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing after experiencing encouraging mid-stage trial results.